Persisting Salivary Igg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Salivary IgG to SARS-CoV-2 after mild COVID-19
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms.
Concerns of COVID reinfection
Symptoms of SARS-CoV-2, the underlying agent for coronavirus disease 2019 (COVID-19), vary massively amongst populations of different age groups and health conditions. Most notably, people over the age of 60, and those with underlying health conditions – predominantly lung and autoimmune – tend to suffer worse than younger individuals. Older age groups especially suffer more fatalities and more serious afflictions. ....

Michael Burgessmar , Michael Burgess , Persisting Salivary Igg , After Mild , Complementary Approach , Population Surveys , Sars Cov 2 , Corona Virus , Coronavirus Disease Covid 19 , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , மைக்கேல் பர்கஸ் , நிரப்பு அணுகுமுறை , பாப்யுலேஶந் ஆய்வுகள் , கொரோனா வைரஸ் , சர்வதேச பரவல் , கடுமையானது எடுப்போசை சுவாச , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி ,